New cancer vaccine to stop disease before it takes hold in the body - Pharmaceutical giant GSK and the University of Oxford ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...
A new cancer vaccine is being developed which scientists hope could target the disease before it takes hold. The University ...